Home > About Us > Our Story
InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug discovery efforts.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.
At InVivo Biosystems, we’re passionate about creating an inclusive workplace that encourages, supports and celebrates diversity. These are not just words for us – we actively seek to create an environment that reflects the global community we serve and where everyone feels empowered to bring their full, authentic selves to work.
We are scientists, researchers and barrier breakers. We are nature lovers, readers, hikers, artists, gardeners, sports enthusiasts, friends and family members – we are unique individuals. We believe diversity, equity and inclusion drive innovation. Together, we spark insights to create a better, healthier world.
University of Oregon Professor Shawn Lockery applied microfluidics techniques, which involve precise control and manipulation of constrained
NemaMetrix was one of the five finalists who received the award under the Obama Administration. The ScreenChip System was considered a disruptive
NemaMetrix adds the capability of creating custom transgenics by joining forces with Knudra Transgenics, a pioneer and an expert in providing
NemaMetrix's in vivo analytical services produce data and insights for companies that need to make go/no-go decisions quickly and help researchers
The company adds the capability of creating genetic models using zebrafish for understanding gene function, basic biology, and more precisely modeling human diseases.
While more than 2,000 companies applied for the opportunity to pitch at Demo Day, NemaMetrix was one of 40 companies chosen to present at the A-ha!
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.
Evangeline Gonzalez has more than 17 years of commercialization experience within the biotechnology industry and has successfully led Market Development and Product Development for a wide array of global businesses ranging from Protein Analysis, Sequencing and Molecular Biology technologies.
Gonzalez joins Advanced Cell Diagnostics from Life Technologies, a 3.7 billion dollar company where she was most recently Chief Marketing Officer- Life Sciences and was responsible for facilitating growth and global market development strategy for the Life Science Division.
Chockalingam “Palani” Palaniappan is the chief technology officer at Epic Sciences. An accomplished global life sciences innovation executive with more than 20 years of global leadership experience across three multinational corporations, GE Healthcare, Life Technologies, and Terumo BCT, delivering over $500M in career revenue. Palani’s proven track record in managing products, people and process spans diverse fields from life science tool companies to the MedTech Industry. He has helped architect many transformative products at the interface of science and technology for scientific and clinical applications including genomics, proteomics, cell biology tools to patient connected engineering devices in health.
Before joining Epic Sciences, Palani was the executive vice president of Innovation and Development and a board member of the Terumo Global Blood Management at Terumo BCT, a global leader in blood management, therapeutic apheresis, cell therapy and regenerative medicine. Prior to this role, he served as the vice president for Research and Development for Cellular Analysis at Life Technologies. Preceding that, he was the head of Molecular Diagnostics for the Amersham Life Sciences unit of GE Healthcare. Palani has a PhD in the field of biological sciences from Northern Illinois University, followed on by a post-doctoral fellowship at the University of Rochester in HIV biology.
Rick Miller founded the Avamere Group in 1995 with the acquisition of a single skilled nursing facility in Hillsboro, Oregon. He has served as CEO since 2018.
In 2010 Rick co-founded the venture capital firm, Rogue Venture Partners. Rogue invests primarily in Oregon-based entrepreneurs and early-stage businesses with funding and mentorship.
Harold brings more than 25 years of experience in Operations, Logistics, and Supply Chain Management. His experience includes implementing Kaizen, Lean Manufacturing, and ISO9000 during large retail growth periods, leading multiple teams, and the logistics side of large distribution centers.
